What question did this study set out to answer?

The study aims to explore the link between accelerated biological aging and the progression of cerebral small vessel disease (CSVD).

April 13, 2026

Associations of Accelerated Biological Aging With the Presence and Longitudinal Progression of Cerebral Small Vessel Disease

Key Points

The study aims to explore the link between accelerated biological aging and the progression of cerebral small vessel disease (CSVD).
Community-based cohort design
Assessment of biological aging through KDMAge and PhenoAge
Longitudinal analysis of CSVD progression
Monitoring development of new lacunes and new CMBs
Higher levels of biological aging residuals are associated with increased odds of CSVD progression.
Notable findings include the emergence of new lacunes and new cerebral microbleeds (CMBs).
The biomarker-based biological aging model highlights individuals at risk for clinically significant CSVD progression.

Abstract

This community-based cohort study demonstrated that BA residuals, particularly KDMAge and PhenoAge, were associated with higher odds of CSVD progression, especially with development of new lacunes and new CMBs. Biomarker-based BA residual may help identify individuals at higher risk of clinically relevant CSVD progression. Future studies with longer follow-up periods and more diverse cohorts are warranted to validate these findings.

Associations of Accelerated Biological Aging With the Presence and Longitudinal Progression of Cerebral Small Vessel Disease

Key Points

Abstract

Cite This Study

Also Consider

Also Consider